Dow Up 0.36% Nasdaq Up 0.12%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.54 Down 0.09(3.42%) Aug 21, 4:00PM EDT
Prev Close:2.63
Open:2.61
Bid:2.53 x 2000
Ask:4.28 x 300
1y Target Est:6.50
Beta:1.22
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.52 - 2.67
52wk Range:2.31 - 5.00
Volume:294,499
Avg Vol (3m):468,252
Market Cap:222.99M
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLDown 3.42%222.99M
AMGNDown 0.11%100.67B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.08
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback